These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2347956)

  • 1. Lack of probenecid effect on nonrenal excretion of ceftriaxone in anephric patients.
    Patel IH; Soni PP; Carbone JJ; Audet PR; Morrison G; Gibson GA
    J Clin Pharmacol; 1990 May; 30(5):449-53. PubMed ID: 2347956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probenecid on the elimination and protein binding of ceftriaxone.
    Stoeckel K; Trueb V; Dubach UC; McNamara PJ
    Eur J Clin Pharmacol; 1988; 34(2):151-6. PubMed ID: 3383987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ceftriaxone in hemodialysis].
    Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K; Koup JR
    Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.
    Hedaya MA; Sawchuk RJ
    J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose ceftriaxone kinetics in functionally anephric patients.
    Stoeckel K; McNamara PJ; Hoppe-Seyler G; Blumberg A; Keller E
    Clin Pharmacol Ther; 1983 May; 33(5):633-41. PubMed ID: 6301740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats.
    Fujita T; Ishihara K; Yasuda S; Nakamura T; Maeda M; Kobayashi M; Sahashi K; Ikeda Y; Kumagai Y; Majima M
    J Pharmacol Exp Ther; 2012 Jun; 341(3):626-33. PubMed ID: 22389425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffusion of ceftriaxone in the renal parenchyma].
    Freney J; Mongin-Long D; Meugnier H; Nervi C; Laville M; Zech P; Fleurette J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):727-9. PubMed ID: 3309805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora.
    Arvidsson A; Leijd B; Nord CE; Angelin B
    Eur J Clin Invest; 1988 Jun; 18(3):261-6. PubMed ID: 3138129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
    Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
    Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probenecid on the pharmacokinetics and pharmacodynamics of procainamide.
    Lam YW; Boyd RA; Chin SK; Chang D; Giacomini KM
    J Clin Pharmacol; 1991 May; 31(5):429-32. PubMed ID: 2050827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration.
    Wong SL; Hedaya MA; Sawchuk RJ
    Pharm Res; 1992 Feb; 9(2):228-35. PubMed ID: 1553347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
    Savina PM; Brouwer KL
    Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion.
    Shin YJ; Lee JH; Oh JH; Lee YJ
    J Appl Toxicol; 2013 Jun; 33(6):511-5. PubMed ID: 22161506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced HPLC-MS/MS method for the quantitative determination of the co-administered drugs ceftriaxone sodium and lidocaine hydrochloride in human plasma following an intramuscular injection and application to a pharmacokinetic study.
    Mohamed D; Kamal M
    Biomed Chromatogr; 2018 Oct; 32(10):e4322. PubMed ID: 29934999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of probenecid on the renal elimination of cimetidine.
    Gisclon LG; Boyd RA; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Apr; 45(4):444-52. PubMed ID: 2702802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.